pros and cons of tirzepatide Can Help You Lose Weight? what are the pros and

Current Retatrutide phase 3 clinical trials have proven 92% participants have lost 24-30% of total body weight in as little as 48 weeks

[] However, the treatment process can be lengthy, challenging, and uncertain, with incontinence and erectile dysfunction as severe side effects

Gallwitz B, Rosenstock J, Rauch T, Bhattacharya S, Patel S, von Eynatten M, Dugi KA, Woerle HJ: 2-year efficacy and safety of linagliptin compared with glimepiride in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, non-inferiority trial

Tirzepatide is currently approved for Type 2 diabetes under the name Mounjaro

Patients should be told why a compounded product is being recommended instead of an FDA-approved alternative